Protalix BioTherapeutics (PLX) Return on Invested Capital (QoQ) (2024 - 2025)

Protalix BioTherapeutics (PLX) Return on Invested Capital (QoQ) (2024 - 2025) Analysis & Trends

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Oculis Holding AG	66,741.39 Bn	66,741.11 Bn	-
2	Nanobiotix	1,912.31 Bn	1,912.25 Bn	-
3	Akari Therapeutics	1,009.43 Bn	1,009.43 Bn	-
4	BeOne Medicines	467.15 Bn	462.36 Bn	1.35 Bn
5	Vertex Pharmaceuticals	123.00 Bn	115.76 Bn	2.59 Bn
6	Regeneron Pharmaceuticals	70.22 Bn	61.47 Bn	3.31 Bn
7	Belite Bio	62.93 Bn	62.93 Bn	-
8	Argenx Se	55.76 Bn	50.57 Bn	1.41 Bn
9	Alnylam Pharmaceuticals	37.70 Bn	34.69 Bn	959.66 Mn
10	Protalix BioTherapeutics	193.63 Mn	182.84 Mn	29.62 Mn

Download Data